Derek N. Adams

Director, Kalaris Therapeutics, Inc.

Companies

Kalaris Therapeutics, Inc.Board member Mar 3, 2023 to Jun 7, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kalaris Therapeutics, Inc. KLRS70,000 shares²$153.3K at $2.19Jun 6, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 6, 2024Granted 35,000 shares of Kalaris Therapeutics, Inc.²
May 11, 2023Granted 35,000 shares of Kalaris Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKalaris Therapeutics, Inc., Board member
2
SEC EDGARKalaris Therapeutics, Inc. shares after the filing of Jun 6, 2024
3
SEC EDGARForm 4 filed May 12, 2023